Top Story

VIDEO: Ibrutinib yields superior PFS vs. standard care in chronic lymphocytic leukemia

December 13, 2018
Meeting News

Allogeneic stem cell transplant induces long-term responses in follicular lymphoma

December 13, 2018
Nonmyeloablative allogeneic stem cell transplant results in complete responses that last for up to a decade among patients with relapsed follicular lymphoma, including…
Meeting News

Combination treatment with rituximab demonstrates ‘excellent’ results as induction therapy

December 13, 2018
Induction therapy with rituximab and bendamustine followed by rituximab plus high-dose cytarabine and then an autologous stem cell transplant increased durable…
Meeting NewsPerspective

Gut microbial diversity before stem cell transplantation may impact survival

December 13, 2018
SAN DIEGO — Higher gut microbial diversity was associated with improved survival in a multinational cohort of patients undergoing hematopoietic stem cell…
Clinical Trials Snapshot

Use of Ligand-Inducible Autologous T-cells Engineered to Target PSCA on Tumor Cells in Selected Advanced Solid Tumors

Cell Therapy Next, December 2018
Phase 1/2 study looking to evaluate the safety and activity of BPX-601 in previously treated advanced solid tumors (gastric, pancreatic or prostate) expressing high…
More Headlines »

Exploring New Immune Checkpoint Inhibitor Paradigms in Advanced Melanoma

This activity is supported by an educational grant from Bristol-Myers Squibb.

The integration of immune checkpoint inhibitors into treatment algorithms for the management of advanced genitourinary…
More »
Meeting News

VIDEO: CV effects of vitamin D, omega-3 supplements remain unclear

November 24, 2018
More »
Resource Centers
ASH Annual Meeting and Exposition

ASH Annual Meeting and Exposition


Decisions, Decisions: Differentiating Checkpoint Inhibitors for Bladder Cancer

This activity is supported by an educational grant from AstraZeneca Pharmaceuticals LP.

Lung cancer is a leading cause of cancer death worldwide. The American Cancer Society estimates that there will be…
More »
Current Issues
View the Current Issue
HemOnc Today Cell Therapy Next